MYRIAD GENETICS, INC. Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31)
MYRIAD GENETICS, INC. (MYGN) reported Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) of $51.10 million for the 1-month period ending 2013-09-30, per its 10-Q filed 2013-11-12.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount · last filed 2013-11-12
- MYRIAD GENETICS, INC. stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for the quarter ending 2012-09-30 was $53.50M.
- MYRIAD GENETICS, INC. stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for fiscal 2012 was $200.00M, a 611.31% increase from fiscal 2011.
- MYRIAD GENETICS, INC. stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for fiscal 2011 was $28.12M.
| Period end | Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) 1 month | Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) 3 month | Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) 12 month |
|---|---|---|---|
| 2013-09-30 | $51.10M 10-Q · filed 2013-11-12 | ||
| 2013-03-31 | $174.90M 10-Q · filed 2013-05-08 | ||
| 2012-12-31 | $19.80M 10-Q · filed 2013-02-06 | ||
| 2012-09-30 | $53.50M 10-Q · filed 2012-11-09 | ||
| 2012-06-30 | $200.00M 10-K · filed 2012-08-15 | ||
| 2011-06-30 | $28.12M 10-K · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |